The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
β-lactam antibiotics: An overview from a medicinal chemistry perspective
Abstract
β-Lactam antibiotics are one of the most relevant drug classes of antibacterial agents worldwide. The discovery and the market of first β-lactam antibiotic (Penicillin G) is a symbolic landmark of modern chemotherapy. Since then, several other β-lactam antibiotics have been introduced in the therapy, revolutionizing the treatment of bacterial infections. Their antibacterial efficacy has been kept in check by the emergence of bacterial resistance. Among the resistance mechanisms, the expression of β-lactamase enzymes is one of the most studied and prevalent. The combined use of beta-lactamase inhibitors with broad spectrum activity β-lactam antibiotics has been an effective strategy to circumvent the resistance issue. This review discusses, with a focus on structural aspects, the different classes of beta-lactam antibiotics (penicillins, cephalosporins, carbapenems, monobactams and penems) in light of their stability, sensitivity to β-lactamases, mechanism of action and spectrum of antimicrobial activity. β-Lactamase inhibitors (structurally correlated and non-correlated to the β-lactam system) and their proposed inhibition mechanisms are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Waves of resistance: Staphylococcus aureus in the antibiotic era
Chambers, H. F., & DeLeo, F. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2200 · Cited by 2,718
A functional classification scheme for beta-lactamases and its correlation with molecular structure
Bush, K., Jacoby, G. A., & Medeiros, A. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1211 · Cited by 2,475
Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research
Turner, N. A., Sharma-Kuinkel, B. K., Maskarinec, S. A., Eichenberger, E. M., Shah, P. P., Carugati, M., Holland, T. L., & Fowler, V. G. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0147-4 · Cited by 2,051
Ambler, R. P. (1980) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1980.0049 · Cited by 1,823
Three Decades of β-Lactamase Inhibitors
Drawz, S. M., & Bonomo, R. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00037-09 · Cited by 1,709
Fleming, A. (1929) · PubMed Central · Cited by 1,647
Carbapenems: Past, Present, and Future
Papp-Wallace, K. M., Endimiani, A., Taracila, M. A., & Bonomo, R. A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00296-11 · Cited by 1,502
An Enzyme from Bacteria able to Destroy Penicillin
ABRAHAM, E. P., & CHAIN, E. (1940) · Nature · doi:10.1038/146837a0 · Cited by 1,333
From the regulation of peptidoglycan synthesis to bacterial growth and morphology
Typas, A., Banzhaf, M., Gross, C. A., & Vollmer, W. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2677 · Cited by 1,273
THE PHARMACOLOGICAL BASIS OF THERAPEUTICS
GOODMAN, L. S., GILMAN, A., & Lasdon, W. S. (1967) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196701000-00028 · Cited by 1,018
β-Lactamases and β-Lactamase Inhibitors in the 21st Century
Tooke, C. L., Hinchliffe, P., Bragginton, E. C., Colenso, C. K., Hirvonen, V. H. A., Takebayashi, Y., & Spencer, J. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.04.002 · Cited by 1,016
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
Fisher, J. F., Meroueh, S. O., & Mobashery, S. (2005) · Chemical Reviews · doi:10.1021/cr030102i · Cited by 913
Further Observations on Penicillin
Abraham, E. P., Chain, E., Fletcher, C. M., Gardner, A. D., Heatley, N. G., Jennings, M. A., & Florey, H. W. (1941) · The Lancet · doi:10.1016/s0140-6736(00)72122-2 · Cited by 821
Carbapenem Resistance: A Review
Codjoe, F., & Donkor, E. (2017) · Medical Sciences · doi:10.3390/medsci6010001 · Cited by 746
Beta-lactamase database (BLDB) – structure and function
Naas, T., Oueslati, S., Bonnin, R. A., Dabos, M. L., Zavala, A., Dortet, L., Retailleau, P., & Iorga, B. I. (2017) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2017.1344235 · Cited by 701
Bioisosterism: A Useful Strategy for Molecular Modification and Drug Design
Lima, L., & Barreiro, E. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867053363540 · Cited by 672
Self-citationSERINE β-LACTAMASES AND PENICILLIN-BINDING PROTEINS
Ghuysen, J.-M. (1991) · Annual Review of Microbiology · doi:10.1146/annurev.mi.45.100191.000345 · Cited by 628
Evolution and Dissemination of β-Lactamases Accelerated by Generations of β-Lactam Antibiotics
Medeiros, A. A. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s19 · Cited by 587
Gram-positive bacterial cell envelopes: The impact on the activity of antimicrobial peptides
Malanovic, N., & Lohner, K. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.11.004 · Cited by 586
Avibactam is a covalent, reversible, non–β-lactam β-lactamase inhibitor
Ehmann, D. E., Jahić, H., Ross, P. L., Gu, R.-F., Hu, J., Kern, G., Walkup, G. K., & Fisher, S. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205073109 · Cited by 545
46th Interscience Conference on Antimicrobial Agents and Chemotherapy
McConnell, J. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70621-1 · Cited by 541
Extraction of a Highly Potent Penicillin Inactivator from Penicillin Resistant Staphylococci
Kirby, W. M. M. (1944) · Science · doi:10.1126/science.99.2579.452 · Cited by 502
Penicillin Binding Proteins: key players in bacterial cell cycle and drug resistance processes
Macheboeuf, P., Contreras-Martel, C., Job, V., Dideberg, O., & Dessen, A. (2006) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2006.00024.x · Cited by 447
Beta‐lactam antibiotics: from antibiosis to resistance and bacteriology
KONG, K., SCHNEPER, L., & MATHEE, K. (2010) · APMIS · doi:10.1111/j.1600-0463.2009.02563.x · Cited by 433
β-Lactam antibiotic resistance: a current structural perspective
Wilke, M. S., Lovering, A. L., & Strynadka, N. C. (2005) · Current Opinion in Microbiology · doi:10.1016/j.mib.2005.08.016 · Cited by 383
Blumberg, P. M., & Strominger, J. L. (1974) · Bacteriological Reviews · doi:10.1128/br.38.3.291-335.1974 · Cited by 381
Carbapenem-hydrolyzing beta-lactamases
Rasmussen, B. A., & Bush, K. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.2.223 · Cited by 361
Cefepime-induced neurotoxicity: a systematic review
Payne, L. E., Gagnon, D. J., Riker, R. R., Seder, D. B., Glisic, E. K., Morris, J. G., & Fraser, G. L. (2017) · Critical Care · doi:10.1186/s13054-017-1856-1 · Cited by 345
Kropp, H., Sundelof, J. G., Hajdu, R., & Kahan, F. M. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.22.1.62 · Cited by 339
Structure of a cephalosporin synthase
Valegård, K., van Scheltinga, A. C. T., Lloyd, M. D., Hara, T., Ramaswamy, S., Perrakis, A., Thompson, A., Lee, H.-J., Baldwin, J. E., Schofield, C. J., et al. (1998) · Nature · doi:10.1038/29575 · Cited by 337
Sulfazecin and isosulfazecin, novel β-lactam antibiotics of bacterial origin
Imada, A., Kitano, K., Kintaka, K., Muroi, M., & Asai, M. (1981) · Nature · doi:10.1038/289590a0 · Cited by 335
Carbapenemases: a problem in waiting?
Livermore, D. M., & Woodford, N. (2000) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00128-4 · Cited by 323
Sykes, R. B., Bonner, D. P., Bush, K., & Georgopapadakou, N. H. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.21.1.85 · Cited by 314
Thienamycin: development of imipenem-cilastatin
Kahan, F. M., Kropp, H., Sundelof, J. G., & Birnbaum, J. (1983) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/12.suppl_d.1 · Cited by 313
Cefuroxime: A Review of its Antibacterial Activity, Pharmacological Properties and Therapeutic Use
Brogden, R. N., Heel, R. C., Speight, T. M., & Avery, G. S. (1979) · Drugs · doi:10.2165/00003495-197917040-00001 · Cited by 311
Characterization of beta-lactamases
Bush, K. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.3.259 · Cited by 305
Monocyclic β-lactam antibiotics produced by bacteria
Sykes, R. B., Cimarusti, C. M., Bonner, D. P., Bush, K., Floyd, D. M., Georgopapadakou, N. H., Koster, W. H., Liu, W. C., Parker, W. L., Principe, P. A., et al. (1981) · Nature · doi:10.1038/291489a0 · Cited by 304
Multiple antibiotic resistance and efflux
Nikaido, H. (1998) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(98)80083-0 · Cited by 301
Cephalosporins and Penicillins: Chemistry and Biology
Flynn, E. H. (1972) · Cited by 296
Biosynthesis of the Peptidoglycan of Bacterial Cell Walls
Izaki, K., Matsuhashi, M., & Strominger, J. L. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)93393-4 · Cited by 290
New β-Lactamase Inhibitors: a Therapeutic Renaissance in an MDR World
Drawz, S. M., Papp-Wallace, K. M., & Bonomo, R. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00826-13 · Cited by 286
Comparative Stability of Cephalosporins in Aqueous Solution: Kinetics and Mechanisms of Degradation
Yamana, T., & Tsuji, A. (1976) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600651104 · Cited by 271
Efficacy and safety of cefepime: a systematic review and meta-analysis
Yahav, D., Paul, M., Fraser, A., Sarid, N., & Leibovici, L. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70109-3 · Cited by 265
The Use of Cephalosporins in Penicillin-allergic Patients: A Literature Review
Campagna, J. D., Bond, M. C., Schabelman, E., & Hayes, B. D. (2012) · The Journal of Emergency Medicine · doi:10.1016/j.jemermed.2011.05.035 · Cited by 243
A Review on Bacterial Resistance to Carbapenems: epidemiology, Detection and Treatment Options
Elshamy, A. A., & Aboshanab, K. M. (2020) · Future Science OA · doi:10.2144/fsoa-2019-0098 · Cited by 238
β-Lactam resistance in Staphylococcus aureus: the adaptive resistance of a plastic genome
Fuda, C. C. S., Fisher, J. F., & Mobashery, S. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5148-6 · Cited by 223
The β‐Lactams Strike Back: Ceftazidime‐Avibactam
Zasowski, E. J., Rybak, J. M., & Rybak, M. J. (2015) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1622 · Cited by 218
Fabiane, S. M., Sohi, M. K., Wan, T., Payne, D. J., Bateson, J. H., Mitchell, T., & Sutton, B. J. (1998) · Biochemistry · doi:10.1021/bi980506i · Cited by 215
Recent updates of carbapenem antibiotics
El-Gamal, M. I., Brahim, I., Hisham, N., et al. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.03.022 · Cited by 214
Meropenem: A Review of its Antibacterial Activity, Pharmacokinetic Properties and Clinical Efficacy
Wiseman, L. R., Wagstaff, A. J., Brogden, R. N., & Bryson, H. M. (1995) · Drugs · doi:10.2165/00003495-199550010-00007 · Cited by 209
Kinetic studies on the inactivation of Escherichia coli RTEM β-lactamase by clavulanic acid
Fisher, J., Charnas, R. L., & Knowles, J. R. (1978) · Biochemistry · doi:10.1021/bi00604a024 · Cited by 204
Antunez, C., Blanca-Lopez, N., Torres, M. J., Mayorga, C., Perez-Inestrosa, E., Montañez, M. I., Fernandez, T., & Blanca, M. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.10.032 · Cited by 204
Antibiotic uptake into gram-negative bacteria
Hancock, R. E. W., & Bell, A. (1988) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01975036 · Cited by 201
Lahiri, S. D., Johnstone, M. R., Ross, P. L., McLaughlin, R. E., Olivier, N. B., & Alm, R. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03057-14 · Cited by 197
Cephalosporins: A Focus on Side Chains and β-Lactam Cross-Reactivity
Chaudhry, S. B., Veve, M. P., & Wagner, J. L. (2019) · Pharmacy · doi:10.3390/pharmacy7030103 · Cited by 197
Yocum, R. R., Rasmussen, J. R., & Strominger, J. L. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85621-1 · Cited by 192
Todd, P. A., & Benfield, P. (1990) · Drugs · doi:10.2165/00003495-199039020-00008 · Cited by 191
Mainardi, J.-L., Villet, R., Bugg, T. D., Mayer, C., & Arthur, M. (2008) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2007.00097.x · Cited by 184
Third-generation cephalosporins
Klein, N. C., & Cunha, B. A. (1995) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30034-7 · Cited by 181
Amoxycillin: A new Semi-synthetic Penicillin
Sutherland, R., Croydon, E. A. P., & Rolinson, G. N. (1972) · BMJ · doi:10.1136/bmj.3.5817.13 · Cited by 178
Molecular analysis of beta-lactamase structure and function
Majiduddin, F. K., Materon, I. C., & Palzkill, T. G. (2002) · International Journal of Medical Microbiology · doi:10.1078/1438-4221-00198 · Cited by 175
Louis Pasteur, the father of immunology?
Smith, K. A. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00068 · Cited by 172
Zhanel, G. G., Sniezek, G., Schweizer, F., Zelenitsky, S. A., Lagacé-Wiens, P. R. S., Rubinstein, E., Gin, A. S., Hoban, D. J., & Karlowsky, J. A. (2009) · Drugs · doi:10.2165/00003495-200969070-00003 · Cited by 168
Han, S., Zaniewski, R. P., Marr, E. S., Lacey, B. M., Tomaras, A. P., Evdokimov, A., Miller, J. R., & Shanmugasundaram, V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013092107 · Cited by 166
Penicillin Allergy: The Formation of the Penicilloyl Determinant
Batchelor, F. R., Dewdney, J. M., & GAZZARD, D. (1965) · Nature · doi:10.1038/206362a0 · Cited by 157
Sauvage, E., & Terrak, M. (2016) · Antibiotics · doi:10.3390/antibiotics5010012 · Cited by 154
Ertapenem: A Review of its Use in the Treatment of Bacterial Infections
Keating, G. M., & Perry, C. M. (2005) · Drugs · doi:10.2165/00003495-200565150-00013 · Cited by 149
Biedenbach, D. J., Kazmierczak, K. M., Bouchillon, S. K., Sahm, D. F., & Bradford, P. A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00206-15 · Cited by 141
Imtiaz, U., Billings, E. M., Knox, J. R., Manavathu, E. K., Lerner, S. A., & Mobashery, S. (1993) · Journal of the American Chemical Society · doi:10.1021/ja00064a003 · Cited by 138
Molecular evolution of bacterial β-lactam resistance
Knox, J. R., Moews, P. C., & Frère, J. (1996) · Chemistry & Biology · doi:10.1016/s1074-5521(96)90182-9 · Cited by 132
A review of the antimicrobial activity of clavulanate
Finlay, J. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg286 · Cited by 129
The Mechanisms of Catalysis by Metallo β‐Lactamases
Page, M. I., & Badarau, A. (2008) · Bioinorganic Chemistry and Applications · doi:10.1155/2008/576297 · Cited by 129
Saudagar, P. S., Survase, S. A., & Singhal, R. S. (2008) · Biotechnology Advances · doi:10.1016/j.biotechadv.2008.03.002 · Cited by 128
Meropenem: A Review of its Use in Patients in Intensive Care
Hurst, M., & Lamb, H. M. (2000) · Drugs · doi:10.2165/00003495-200059030-00016 · Cited by 120
Buynak, J. D. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.11.012 · Cited by 120
Ertapenem: review of a new carbapenem
Zhanel, G. G., Johanson, C., Embil, J. M., Noreddin, A. M., Gin, A. S., Vercaigne, L. M., & Hoban, D. J. (2005) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.3.1.23 · Cited by 119
β-Lactam Resistance Mechanisms: Gram-Positive Bacteria and Mycobacterium tuberculosisPreprint
Fisher, J. F., & Mobashery, S. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025221 · Cited by 116
A review of the pharmacokinetics and pharmacodynamics of aztreonam
Ramsey, C. B., & MacGowan, A. P. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw231 · Cited by 114
Fisher, J. F., Charnas, R. L., Bradley, S. M., & Knowles, J. R. (1981) · Biochemistry · doi:10.1021/bi00513a004 · Cited by 111
CLAVULANIC ACID AND AMOXYCILLIN: A CLINICAL, BACTERIOLOGICAL, AND PHARMACOLOGICAL STUDY
Ball, A. P. (1980) · The Lancet · doi:10.1016/s0140-6736(80)91118-6 · Cited by 110
Cephalosporin use in treatment of patients with penicillin allergies
DePestel, D. D., Benninger, M. S., Danziger, L. H., LaPlante, K. L., May, C., Luskin, A. T., Michael, P., & Hadley, J. A. (2008) · Journal of the American Pharmacists Association · doi:10.1331/japha.2008.07006 · Cited by 109
Class A β-lactamases—enzyme-inhibitor interactions and resistance
Yang, Y., Rasmussen, B. A., & Shlaes, D. M. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00027-3 · Cited by 109
Chemical studies on the inactivation of Escherichia coli RTEM β-lactamase by clavulanic acid
Charnas, R. L., Fisher, J. F., & Knowles, J. R. (1978) · Biochemistry · doi:10.1021/bi00604a025 · Cited by 109
Strominger, J. L., Izaki, K., Matsuhashi, M., & Tipper, D. J. (1967) · PubMed · Cited by 107
Molecular Features of Penicillin Allergy
Weltzien, H. U., & Padovan, E. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00122.x · Cited by 105
Feltrin, F., Alba, P., Kraushaar, B., Ianzano, A., Argudín, M. Á., Matteo, P. D., Porrero, M. C., Aarestrup, F. M., Butaye, P., Franco, A., et al. (2015) · Applied and Environmental Microbiology · doi:10.1128/aem.02854-15 · Cited by 104
Breaking down the cell wall: Strategies for antibiotic discovery targeting bacterial transpeptidases
Cochrane, S. A., & Lohans, C. T. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112262 · Cited by 98
Perry, C. M., & Ibbotson, T. (2002) · Drugs · doi:10.2165/00003495-200262150-00005 · Cited by 97
Gaeta, F., Valluzzi, R. L., Alonzi, C., Maggioletti, M., Caruso, C., & Romano, A. G. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.10.011 · Cited by 91
Catalytic Mechanism of Class B2 Metallo-β-lactamase
Xu, D., Xie, D., & Guo, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512517200 · Cited by 88
Waxman, D. J., & Strominger, J. L. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85620-x · Cited by 85
A Structure-Based Analysis of the Inhibition of Class A .beta.-Lactamases by Sulbactam
Imtiaz, U., Billings, E. M., Knox, J. R., & Mobashery, S. (1994) · Biochemistry · doi:10.1021/bi00185a009 · Cited by 83
Somboro, A. M., Sekyere, J. O., Amoako, D. G., Essack, S. Y., & Bester, L. A. (2018) · Applied and Environmental Microbiology · doi:10.1128/aem.00698-18 · Cited by 83
Tebipenem, the first oral carbapenem antibiotic
Jain, A., Utley, L., Parr, T. R., Zabawa, T. P., & Pucci, M. J. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1496821 · Cited by 78
The pharmacological basis of therapeutics
Salzmann, J. A. (1977) · American Journal of Orthodontics · doi:10.1016/s0002-9416(77)90402-x · Cited by 77
New light on the history of penicillin
Hare, R. (1982) · Medical History · doi:10.1017/s0025727300040758 · Cited by 73
Hypersensitivity reactions to β-lactams: relevance of hapten-protein conjugates.
Ariza, A., Mayorga, C., Fernández, T. D., Barbero, N., Martín-Serrano, A., Pérez‐Sala, D., Sánchez-Gómez, F. J., Blanca, M., Torres, M. J., & Montañez, M. I. (2015) · PubMed · Cited by 70
Ceftobiprole: drug evaluation and place in therapy
Giacobbe, D. R., Rosa, F. G. D., Bono, V. D., Grossi, P., Pea, F., Petrosillo, N., Rossolini, G. M., Tascini, C., Tumbarello, M., Viale, P., et al. (2019) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2019.1667229 · Cited by 70
Class D β-lactamases do exist in Gram-positive bacteria
Tóth, M., Antunes, N. T., Stewart, N. K., Frase, H., Bhattacharya, M., Smith, C. A., & Vakulenko, S. B. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1950 · Cited by 67
Cefepime: A new fourth-generation cephalosporin
Okamoto, M. P., Nakahiro, R. K., Chin, A., Bedikian, A., & Gill, M. A. (1994) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/51.4.463 · Cited by 65
Pharmaceutical Innovation: Revolutionizing Human Health
Landau, R., Achilladelis, B., & Scriabine, A. (1999) · Medical Entomology and Zoology · Cited by 58
Mechanisms of resistance to beta-lactam antibiotics.
Dm, L. (1991) · PubMed · Cited by 54
Homologation: A Versatile Molecular Modification Strategy to Drug Discovery
Lima, L. M., Alves, M. A., & do Amaral, D. N. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190808145235 · Cited by 54
Self-citationMcEntee, L., Johnson, A., Farrington, N., Unsworth, J., Dane, A. L., Jain, A., Cotroneo, N. S., Critchley, I. A., Melnick, D., Parr, T., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00603-19 · Cited by 53
Welte, T., Kantecki, M., Stone, G. G., & Hammond, J. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.08.012 · Cited by 53
Garau, J., Wilson, W. R., Wood, M., & Carlet, J. M. (1997) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.1997.tb00649.x · Cited by 52
Hikida, M., Itahashi, K., Igarashi, A., Shiba, T., & Kitamura, M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.8.2010 · Cited by 52
Asai, M., Haibara, K., Muroi, M., Kintaka, K., & Kishi, T. (1981) · The Journal of Antibiotics · doi:10.7164/antibiotics.34.621 · Cited by 52
Smith, P. W., Zuccotto, F., Bates, R. H., Martínez, M. S., Read, K. D., Peet, C. F., & Epemolu, O. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.8b00160 · Cited by 49
Palacios, A. R., Mojica, M. F., Giannini, E., Taracila, M. A., Bethel, C. R., Alzari, P. M., Otero, L. H., Klinke, S., Llarrull, L. I., Bonomo, R. A., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01754-18 · Cited by 48
Ceftizoxime and other third-generation cephalosporins: structure-activity relationships
Dunn, G. L. (1982) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/10.suppl_c.1 · Cited by 46
In Vitro Activity of Sulopenem, an Oral Penem, against Urinary Isolates of Escherichia coli
Karlowsky, J. A., Adam, H. J., Baxter, M. R., Denisuik, A. J., Lagacé-Wiens, P. R. S., Walkty, A. J., Puttagunta, S., Dunne, M. W., & Zhanel, G. G. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01832-18 · Cited by 43
Ceftaroline Fosamil: A Brief Clinical Review
Shirley, D.-A. T., Heil, E. L., & Johnson, J. K. (2013) · Infectious Diseases and Therapy · doi:10.1007/s40121-013-0010-x · Cited by 41
The Art of Fusion: From Penams and Cephems to Penems
Dalhoff, A., & Thomson, C. J. (2003) · Chemotherapy · doi:10.1159/000070616 · Cited by 41
Vardanyan, R., & Hruby, V. J. (2006) · Elsevier eBooks · doi:10.1016/b978-044452166-8/50032-7 · Cited by 41
Secondary Metabolism and Antimicrobial Metabolites of Penicillium
Kumar, A., Asthana, M., Gupta, A. S., Nigam, D., & Mahajan, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-444-63501-3.00003-x · Cited by 36
Adkinson, N. F., Mendelson, L. M., Ressler, C., & Keogh, J. C. (2018) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2018.09.459 · Cited by 36
Huo, X., Meng, Q., Wang, C., et al. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.02.005 · Cited by 36
Cefamandole--A Review of Chemistry and Microbiology
Kaiser, G. V., Gorman, M., & WEBBER, J. A. (1978) · The Journal of Infectious Diseases · doi:10.1093/infdis/137.supplement.s10 · Cited by 34
The complexity of T cell–mediated penicillin hypersensitivity reactions
Goh, S. J. R., Tuomisto, J. E. E., Purcell, A. W., Mifsud, N. A., & Illing, P. T. (2020) · Allergy · doi:10.1111/all.14355 · Cited by 33
Outer Membrane Channels and Active Transporters for the Uptake of Antibiotics
Braun, V., Bös, C., Braun, M., & Killmann, H. (2001) · The Journal of Infectious Diseases · doi:10.1086/318840 · Cited by 32
Pharmacology of Specific Drug Groups
Kumar, P. N. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-39307-2.00033-3 · Cited by 31
Cefepime: A new fourth-generation cephalosporin
(1994) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/51.4.541 · Cited by 31
Amoxycillin Clavulanate: an Assessment after 15 Years of Clinical Application
Ball, P. D., Geddes, A., & Rolinson, G. N. (1997) · Journal of Chemotherapy · doi:10.1179/joc.1997.9.3.167 · Cited by 30
Raynor, B. D. (1997) · Primary Care Update for OB/GYNS · doi:10.1016/s1068-607x(97)00012-7 · Cited by 30
Protein Engineering of Penicillin Acylase
Tishkov, V. I., Savin, S. S., & Yasnaya, A. S. (2010) · Acta Naturae · doi:10.32607/20758251-2010-2-3-47-61 · Cited by 30
Watkins, R., & Bonomo, R. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-7020-6285-8.00140-4 · Cited by 30
Method for Estimation of Low Outer Membrane Permeability to β-Lactam Antibiotics
Lakaye, B., Dubus, A., Joris, B., & Frère, J. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.2901-2907.2002 · Cited by 29
Kuriyama, T., Karasawa, T., & Williams, D. W. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397043-5.00013-x · Cited by 27
Walsh, F. (2007) · PubMed · Cited by 27
The early years of the penicillin discovery
Chain, E. B. (1979) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(79)90004-x · Cited by 27
Amoxicillin-potassium clavulanate, a β-lactamase-resistant antibiotic combination
Stein, G. E., & Gurwith, M. (1984) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/41.12.2685 · Cited by 26
Immediate cephalosporin allergy
Yuson, C., Kumar, K., Le, A., Ahmadie, A., Banovic, T., Heddle, R. J., Kette, F. E., Smith, W., & Hissaria, P. (2019) · Internal Medicine Journal · doi:10.1111/imj.14229 · Cited by 25
Beta-Lactamase Stability of Faropenem
Dalhoff, A., Nasu, T., & Okamoto, K. (2003) · Chemotherapy · doi:10.1159/000072446 · Cited by 24
Pioneer work on the ‘penicillin phenomenon’, 1870–1876
Selwyn, S. (1979) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/5.3.249 · Cited by 21
Alcaide, B., Aragoncillo, C., & Almendros, P. (2008) · Elsevier eBooks · doi:10.1016/b978-008044992-0.00202-9 · Cited by 20
Penicillin G's function, metabolites, allergy, and resistance.
Canzani, D., & Aldeek, F. (2017) · doi:10.35841/nutrition-human-health.1.1.28-40 · Cited by 19
Efficacy and safety of ceftaroline: systematic review and meta-analysis
Rosanova, M. T., Aguilar, P. S., Sberna, N., & Lede, R. (2018) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936118808655 · Cited by 13
Elucidating the Molecular Basis of Avibactam‐Mediated Inhibition of Class A β‐Lactamases
Das, C. K., & Nair, N. N. (2020) · Chemistry - A European Journal · doi:10.1002/chem.202001261 · Cited by 12
Cited by
Molecular mechanisms of antibiotic resistance revisited
Darby, E. M., Trampari, E., Siasat, P., Gaya, M. S., Alav, I., Webber, M. A., & Blair, J. M. A. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00820-y · Cited by 1,398
Pseudomonas aeruginosa: Infections, Animal Modeling, and Therapeutics
Wood, S. J., Kuzel, T. M., & Shafikhani, S. H. (2023) · Cells · doi:10.3390/cells12010199 · Cited by 254
Role of Metal Availability in Modulating Antibiotic Efficacy
Velez, A. (2025) · The University of North Carolina at Chapel Hill University Libraries · doi:10.17615/qh5n-2n35
Metadata
- Authors
- Lima, L. M., Silva, B. N. M. D., Barbosa, G., & Barreiro, E. J.
- Venue
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2020-12
- Volume
- 208
- Pages
- 112829
- ISSN
- 0223-5234 (ISSN-L)
- OpenAlex
- W3087318638
- Cited by
- 642
- References
- 139
- FWCI
- 19.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.